Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Consumers Researching Business Practices - - ADTN, PWRM, AEA, AAP




Power3 Medical Products, Inc. (OTC:PWRM) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. Power3 Medical will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices. Power3 Medical is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).


ADTRAN, Inc. (NASDAQ:ADTN) reported results for the third quarter of 2010. Sales increased 27% to a record level of $162,957,000 for the quarter, compared to $128,062,000 for the third quarter of 2009. Operating income increased 56% to $45,045,000 for the quarter compared to $28,959,000 for the third quarter of 2009. Net income increased 49% to $32,084,000 for the quarter, compared to $21,583,000 for the third quarter of 2009. Earnings per share, assuming dilution, increased 47% to $0.50 for the quarter, compared to $0.34 for the third quarter of 2009.

ADTRAN, Inc. is a leading global provider of networking and communications equipment, with a portfolio of more than 1,700 solutions for use in the last mile of today's telecommunications networks.


Advance America, Cash Advance Centers, Inc. (NYSE:AEA) reported the results of its operations for the quarter and six months ended June 30, 2010. Highlights Six Months and Quarter ended June 30, 2010 encompass: Diluted earnings per share for the six months and quarter were $0.30 and $0.08, respectively; Excluding charges of $2.4 million for legal settlements, diluted earnings per share for the six months and quarter would have been $0.32 and $0.10, respectively; Center gross profit for the quarter increased $6.5 million to $31.1 million, which represents a 26.2% increase over the same period for the prior year; Income before income taxes for the quarter was $9.6 million, an increase of 10.0% over the same period for the prior year; and Excluding legal settlements, income before income taxes for the quarter was $11.9 million, an increase of 37.0% over the same period for the prior year.


Advance Auto Parts, Inc., (NYSE:AAP), a leading automotive aftermarket retailer of parts, batteries, accessories, and maintenance items, declared Carl Hauch will transition to the role of Senior Vice President, Team Member Excellence. Mr. Hauch will be responsible for leading Human Resources and for guiding Team Member development strategies, systems and processes. Mr. Hauch will report to Tami Kozikowski, Chief Development Officer and will re-locate to Roanoke, Virginia.

Headquartered in Roanoke, Va., Advance Auto Parts, a leading automotive aftermarket retailer of parts, accessories, batteries, and maintenance items in the United States, serves both the do-it-yourself and professional installer markets. As of July 17, 2010, Advance Auto Parts operated 3,497 stores in 40 states, Puerto Rico, and the Virgin Islands.




Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has previously received five hundred thousand shares as compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (OTC:PWRM). Recently, Crown Equity Holdings Inc. had received an additional amount of 2,000,000 shares of free trading stock for 60 days of media advertisement, web design and maintenance for Power 3 Medical Products Inc. (OTC:PWRM). Each advertising commitment has now expired.